German-French Diabetes Symposium
(Organized by: Ch. Boitard, E. Van Obberghen, H. Häring, M. Hrabé de Angelis)

• Patrick Collombat, University of Nice Sophia Antipolis, France
  Induction of pancreatic beta-cell neogenesis
• Agnès Lehuen, University of Paris V, France
  Mait cells at the crossroad of microbiota, inflammation and diabetes
• Philippe Froguel, University of Lille, France and Imperial College, London, UK
  (Epi)genetics of Insulin Resistance

Translating Science to Clinics

• Henning Beck-Nielsen, University of Copenhagen, Denmark
  Treatment of type 2 diabetes based on pathophysiology
• Hans-Jürgen Wörle, Boehringer Ingelheim, Germany
  Empa Drug Development; past, present and future and its implications for future drug development

Future Concepts for Diabetes Therapy

• Ron Kahn, Harvard Medical School, USA
  Impact of the Gut Microbiome on Insulin Receptor Signaling
• Stephen O'Rahilly, University of Cambridge, UK
  Human metabolic disease, lessons from genetics

Special Lecture

• Jeffrey Flier, Harvard Medical School, USA
  Irreproducibility of bioscience research: diagnosis, pathogenesis and therapy

The School will be chaired by members of the DZD executive board.